Regulation of cell proliferation and cell death by peroxisome proliferators

被引:19
作者
Cattley, RC [1 ]
机构
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
cell proliferation; cell death; peroxisome proliferators;
D O I
10.1002/jemt.10327
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Peroxisome proliferators cause increases in liver mass in rodents, linked to changes in cell proliferation and cell death of hepatocytes. These effects are reversible upon cessation of treatment. The underlying mechanism of the response in rodent liver is complex, but clearly dependent on activation of the nuclear receptor PPARalpha. Other signaling pathways have been implicated in this response, but evidence is mixed. Differing sensitivity among various species to effects of peroxisome proliferators has been associated with differences in PPARalpha expression and function. Changes in cell proliferation and cell death in neoplastic hepatocytes also have been found in liver tumors caused by long-term treatment with peroxisome proliferators. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 51 条
[1]   Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFα signaling [J].
Anderson, SP ;
Dunn, CS ;
Cattley, RC ;
Corton, JC .
CARCINOGENESIS, 2001, 22 (11) :1843-1851
[2]   COMPARISON OF THE ACUTE AND CHRONIC MITOGENIC EFFECTS OF THE PEROXISOME PROLIFERATORS METHYLCLOFENAPATE AND CLOFIBRIC ACID IN RAT-LIVER [J].
BARRASS, NC ;
PRICE, RJ ;
LAKE, BG ;
ORTON, TC .
CARCINOGENESIS, 1993, 14 (07) :1451-1456
[3]   Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643 [J].
Bojes, HK ;
Germolec, DR ;
Simeonova, P ;
Bruccoleri, A ;
Schoonhoven, R ;
Luster, MI ;
Thurman, RG .
CARCINOGENESIS, 1997, 18 (04) :669-674
[4]  
Bojes HK, 1996, CANCER RES, V56, P1
[5]   DETERMINATION OF THE LENGTH OF THE HISTOLOGICAL STAGES OF APOPTOSIS IN NORMAL LIVER AND IN ALTERED HEPATIC FOCI OF RATS [J].
BURSCH, W ;
PAFFE, S ;
PUTZ, B ;
BARTHEL, G ;
SCHULTEHERMANN, R .
CARCINOGENESIS, 1990, 11 (05) :847-853
[6]   Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? [J].
Cattley, RC ;
DeLuca, J ;
Elcombe, C ;
Fenner-Crisp, P ;
Lake, BG ;
Marsman, DS ;
Pastoor, TA ;
Popp, JA ;
Robinson, DE ;
Schwetz, B ;
Tugwood, J ;
Wahli, W .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1998, 27 (01) :47-60
[7]   Species differences in peroxisome proliferation; mechanisms and relevance [J].
Choudhury, AI ;
Chahal, S ;
Bell, AR ;
Tomlinson, SR ;
Roberts, RA ;
Salter, AM ;
Bell, DR .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 448 (02) :201-212
[8]  
Christensen JG, 1998, CELL GROWTH DIFFER, V9, P815
[9]   DIFFERENCES IN THE STEADY-STATE LEVELS OF C-FOS, C-JUN AND C-MYC MESSENGER-RNA DURING MITOGEN-INDUCED LIVER GROWTH AND COMPENSATORY REGENERATION [J].
CONI, P ;
SIMBULA, G ;
DEPRATI, AC ;
MENEGAZZI, M ;
SUZUKI, H ;
SARMA, DSR ;
LEDDACOLUMBANO, GM ;
COLUMBANO, A .
HEPATOLOGY, 1993, 17 (06) :1109-1116
[10]   Cytokine regulation of liver injury and repair [J].
Diehl, AM .
IMMUNOLOGICAL REVIEWS, 2000, 174 :160-171